Oramed Pharmaceuticals Inc. - Common Stock (ORMP)
Healthcare › Pharmaceutical Preparations
Price History
Feb 9, 2026 — Apr 2, 2026Investment Snapshot
- Trading 65% below Graham Number ($9.72) — significant margin of safety
- Piotroski F-Score 3/9 — signs of financial weakness
- ROE of 17.2% — good return on equity
- Revenue growing at 49% annually
Oramed Pharmaceuticals Inc. - Common Stock (ORMP) is a Healthcare company operating in Pharmaceutical Preparations, listed on the NASDAQ , with a market capitalisation of $137 million . Key value metrics: P/E ratio 4.0, P/B ratio 0.69, Piotroski F-Score 3 out of 9 .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Oramed Pharmaceuticals Inc. - Common Stock — Fundamental Analysis Summary
Oramed Pharmaceuticals Inc. - Common Stock (ORMP) is trading 65% below its Graham Number of $9.72 — a significant margin of safety by Benjamin Graham's standard. The stock carries a low trailing P/E ratio of 4.0x.
On financial health, ORMP shows a weak Piotroski F-Score of 3/9, a signal of deteriorating financial health, and solid return on equity of 17.2% (sector average: -19.8%), and manageable leverage with a debt-to-equity ratio of 0.53.
StockPik's composite Value Score for ORMP is 85/100 — placing it in undervalued territory. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
ORMP reports a thin gross margin of 0.7% (sector average: 33.5%) and a negative operating margin of -625.3%.
ORMP shows revenue growing at 49% year-over-year, with earnings growing at 435%.
ORMP pays a high dividend yield of 7.4%.